Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2014
Opportunities for improvement: experience at one institutionRonald S WaltersJournal of the National Comprehensive Cancer Network : JNCCN|April 8, 2020
The State of Cancer Care in America: Impact of State Policy on Access to High-Quality Cancer CareTerrell Johnson, Lindsey A M Bandini, Kara Martin, et al.Journal of the National Comprehensive Cancer Network : JNCCN|April 12, 2021
Accelerating Advances in Cancer Care Research: A Lookback at the 21st Century Cures Act in 2020Leigh Gallo, Ronald S Walters, Jeff Allen, et al.Clinical Breast Cancer|October 28, 2004
Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancerAna M Gonzalez-Angulo, Ronald S Walters, Robert J Carpenter, et al.Head & Neck|June 5, 2013
Developing a system to track meaningful outcome measures in head and neck cancer treatmentRonald S Walters, Heidi W Albright, Randal S Weber, et al.Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2020
NCCN Policy Summit: Defining, Measuring, and Applying Quality in an Evolving Health Policy Landscape and the Implications for Cancer CareLindsey A M Bandini, Leigh Gallo, Terrell Johnson, et al.Cancer|February 27, 2008
Phase 3 study comparing the use of docetaxel on an every-3-week versus weekly schedule in the treatment of metastatic breast cancerEdgardo Rivera, Jaime A Mejia, Banu K Arun, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancerCatherine M Kelly, Marjorie C Green, Kristine Broglio, et al.Journal of the National Comprehensive Cancer Network : JNCCN|April 23, 2008
NCCN Task Force Report: Oral chemotherapySaul N Weingart, Elizabeth Brown, Peter B Bach, et al.Investigational New Drugs|October 13, 2018
A phase II study of imatinib mesylate and letrozole in patients with hormone receptor-positive metastatic breast cancer expressing c-kit or PDGFR-βClinton Yam, Rashmi K Murthy, Gaiane M Rauch, et al.Pageof 2